Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway
Chenyang Zhang, Meixin Han, Xuelian Zhang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 71-83
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 80
Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease
Yan Qian, Shasha Liu, Yang Sun, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
Marta Wołosowicz, Sławomir Prokopiuk, Tomasz W. Kamiński
Medicina (2022) Vol. 58, Iss. 4, pp. 472-472
Open Access | Times Cited: 39
Dihydromyricetin Attenuates Diabetic Cardiomyopathy by Inhibiting Oxidative Stress, Inflammation and Necroptosis via Sirtuin 3 Activation
Yun Chen, Yangyang Zheng, Ruixiang Chen, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 200-200
Open Access | Times Cited: 29
Ginsenoside Rb1 attenuates doxorubicin induced cardiotoxicity by suppressing autophagy and ferroptosis
Yafei Zhai, Jinmeng Bai, Ying Peng, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 710, pp. 149910-149910
Closed Access | Times Cited: 9
PNGL reduces lipotoxicity in diabetic cardiomyopathy and activates the adiponectin pathway
Jialu Wang, Hongna Tong, Chenyang Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114373-114373
Closed Access | Times Cited: 1
Hypolipidemic effect and molecular mechanism of ginsenosides: a review based on oxidative stress
Wei Jin, Chunrun Li, Shihui Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2
Louyin Ji, Hui Han, Xiaoli Shan, et al.
European Journal of Pharmacology (2024) Vol. 974, pp. 176609-176609
Closed Access | Times Cited: 5
Analyzing Immune Cell Infiltration and Copper Metabolism in Diabetic Foot Ulcers
Wenjuan Yi, Yifan Yuan, Qionglin Bao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3143-3157
Open Access | Times Cited: 5
Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights
Miaomiao Xu, Xiaoguang Liu, Liming Lu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds
Ahmed R. Abdullah, Mahmoud A. Seliem, Emad Gamil Khidr, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Metabolomics fingerprinting uncovered regional and cultivation-specific metabolic signatures in panax notoginseng: insights into geographical and agricultural influences
Zi Chen, Shijia Zhang, Zhiqiang Zhao, et al.
Journal of Food Composition and Analysis (2025), pp. 107617-107617
Closed Access
Mitochondrial dysfunction in heart diseases: Potential therapeutic effects of Panax ginseng
Xinxin Cao, Fan Yao, Bin Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Deciphering the effective components of a TCM formula for atherosclerosis by three-dimensional pattern recognition of exogenous components correlated with endogenous metabolites
Pei Lin, Zifei Qin, Xuanjing Chen, et al.
Journal of Ethnopharmacology (2025), pp. 119647-119647
Closed Access
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice
Meiling Yan, Suping Liu, Wenru Zeng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114919-114919
Open Access | Times Cited: 9
Ginsenoside Rg3 Protects against Diabetic Cardiomyopathy and Promotes Adiponectin Signaling via Activation of PPAR-γ
Chenyang Zhang, Huifang Yu, Jingxue Ye, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16736-16736
Open Access | Times Cited: 9
Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
Lvzhuo Zhang, Shifeng He, Lian Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3564-3582
Closed Access | Times Cited: 3
Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms
Junting Dai, Lulu Qiu, Yimin Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Ginsenosides Restore Lipid and Redox Homeostasis in Mice with Intrahepatic Cholestasis through SIRT1/AMPK Pathways
Guodong Li, Yanjiao Xu, Qianyan Gao, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3938-3938
Open Access | Times Cited: 12
Ginsenoside Rb1 ameliorates the abnormal hepatic glucose metabolism by activating STAT3 in T2DM mice
Weixuan Wang, Wenjing Zhan, Mingjie Liang, et al.
Journal of Functional Foods (2023) Vol. 104, pp. 105534-105534
Open Access | Times Cited: 6
A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
Pengyu Yao, Xiaoni Yang, Yun Qiao
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
Ginsenoside Rb1 improves human nonalcoholic fatty liver disease with liver organoids-on-a-chip
Hui Wang, Yue Zhu, Pengcheng Shi, et al.
Engineered Regeneration (2024) Vol. 5, Iss. 3, pp. 283-294
Open Access | Times Cited: 1
Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity
Boyu Wang, Jiameng Wang, Changxing Liu, et al.
Journal of Applied Toxicology (2024)
Closed Access | Times Cited: 1
Inhibition of Myocardial Remodeling and Heart Failure by Traditional Herbal Medications: Evidence from Ginseng and ginkgo biloba
Morris Karmazyn, Xiaohong Tracey Gan
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 7
Open Access | Times Cited: 3
Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE2/EP4 Signaling Pathway
Mingjie Liang, Wenjing Zhan, Lexun Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3223-3234
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top